Navigation Links
ViroPharma Announces Presentation of Additional HCV-796 Data at,Meeting of The European Association for the Study of the Liver

ith virologic response pattern. The clinical implication of this mutation, if any, will be evaluated in ongoing and future long-term studies.

About Hepatitis C

Hepatitis C is a blood-borne virus recognized as a major cause of chronic hepatitis worldwide. The World Health Organization estimates that 170 million persons worldwide are chronically infected with HCV, and three to four million persons are newly infected globally each year. According to the U.S. Centers for Disease Control and Prevention (CDC), about four million people in the U.S., or 1.8 percent of the population, are infected with HCV.

Currently, there is no specific antiviral agent directed against HCV that is commercially available, and no vaccine for prevention of HCV infection. Several interferon (IFN) products are available worldwide, but there are substantial limitations to the use of these products when given as monotherapy or in conjunction with ribavirin in the treatment of chronic HCV infection. In addition to the relatively poor treatment response in patients infected with genotype 1 HCV, the most common strain in the U.S., Western Europe and Japan, the considerable side effects frequently associated with the use of IFN can lead to discontinuation of therapy in approximately 20 percent of patients.

About ViroPharma Incorporated

ViroPharma Incorporated is committed to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R), approved for oral administration for treatment of antibiotic- associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/pulvules_pi.pdf ). ViroPh
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:12/17/2009)... Connectyx Technologies Holding Group Inc. (Pink Sheets: CTYX) ... partnership with United States Medical Supply, a leading ... and Medications as well as Bladder Control Products ... of the partnership were not disclosed, however Connectyx ... to our growing distribution channel for MedFlash and ...
(Date:12/17/2009)... ANGELES, Dec. 17 Instacare Corp. (OTC ... life-saving and life-enhancing prescription drugs and diagnostics and ... and a leading developer and provider of e-health ... products announced today that as part of the ... has determined to add two new Directors and ...
(Date:12/17/2009)... Pharmaceutical Institute today announced that it has acquired ... in life science courseware. These assets, including ... already extensive library of training resources. ... specialized training solutions for the pharmaceutical and biotech ... Financial terms of the agreement were not disclosed. ...
Breaking Medicine Technology:Connectyx Announces Distribution Partnership with United States Medical Supply 2Connectyx Announces Distribution Partnership with United States Medical Supply 3Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 2Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc. 3NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 1NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 2NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 3NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 4NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 5NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 6NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 7NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 8REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 8669 1REGiMMUNE presents enhanced efficacy data in preclinical transplantation models 8669 2Practice Reps Brings Sales and Marketing to the Business of Medical Practice Management 47434 1Practice Reps Brings Sales and Marketing to the Business of Medical Practice Management 47434 2
(Date:12/17/2009)... 17 Omnicell, Inc ., (Nasdaq: ... system solutions to acute healthcare facilities, today announced ... Health Care Network in Springfield, Missouri, has chosen ... management and supply solutions. ,, "Omnicell,s patient-specific approach ... workflow efficiency, streamline the nurses, access to, distribution ...
(Date:12/17/2009)... Respect for Life" in Majority Leader,s Revisions to ... WASHINGTON, Dec. 17 Americans United for ... letter today to Senate Majority Leader Harry Reid ... Majority Leader,s revisions to a bill - to ... Senator Reid to include "specific language that ensures ...
(Date:12/17/2009)... clothing stores, gas stations -- and adding to obesity epidemic, ... you,re hungry while shopping for a new sofa, don,t despair: ... salty snacks, a new report finds. , In fact, the ... stores to hit most segments of the retail market, say ... the American Journal of Public Health . The ...
(Date:12/17/2009)... outbreak is a good time to get vaccinated, federal ... -- As the current wave of H1N1 swine flu ... that everyone get vaccinated in case another outbreak strikes ... H1N1 flu vaccine have eased, it,s an ideal time ... Secretary Kathleen Sebelius said during a morning press conference. ...
(Date:12/17/2009)... NEW YORK, Dec. 17 Reportlinker.com ... is available in its catalogue: ,, ... designed to provide the animal health industry ... and insight, critical to the development and ... The study,s major objectives include: ,, ...
Breaking Medicine News(10 mins):Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 2Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 3Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 4Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Swine Flu Wanes, But Future Uncertain 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4
... Expert Panel to Discuss Significant Health and Safety Impacts, What Needs ... to Be Done, WASHINGTON, Feb. 25 , ... completed an assessment of the public health workforce shortage -- ... findings and recommended actions., WHY: The ...
... who examined blood test records in a survey of over ... found thousands of cases of probable undiagnosed diabetes. This could ... in UK. , The research is published in the ... was led by Dr Tim Holt of the University of ...
... Billian,s HealthDATA continues to add,new companies ... value of,current subscribers, licenses. In the last ... offering and continues to provide their,customers, with ... have the most current information to guide ...
... ST. PAUL, Minn., Feb. 25 Acuo Technologies, ... the medical imaging,industry for archiving, collaboration and migration ... company achieved 300% growth,over the previous year in ... DICOM Services Grid(TM) software solution; totaling,182 implementations worldwide., ...
... New Enterprise Intelligence Solutions to the Healthcare ... ... 25 HIMSS, Booth #1841 --,Harris Corporation (NYSE: HRS ), ... for healthcare enterprises during the Healthcare,Information and Management Systems Society (HIMSS) ...
... Patient Care with Visibility into Location of Medical Equipment and ... ... Feb. 25 Colubris Networks, the leading,global provider of intelligent wireless ... is working with,AeroScout, Inc., the leading provider of Unified Asset Visibility,solutions, ...
Other Medicine News:Health News:New Assessment Highlights Breadth and Depth of Looming Public Health Workforce Crisis 2Health News:GP's databases could identify tens of thousands with undiagnosed diabetes in UK 2Health News:Billian's HealthDATA(R) Continues to Delight Their Customers with Comprehensive Cutting Edge Healthcare Market Intelligence 2Health News:Billian's HealthDATA(R) Continues to Delight Their Customers with Comprehensive Cutting Edge Healthcare Market Intelligence 3Health News:Acuo Technologies(R) Announces Record Sales and Implementation Growth 2Health News:Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises 2Health News:Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises 3Health News:Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks 2Health News:Colubris Partners with AeroScout to Enable Real-time Location Detection over Wireless Networks 3
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: When high buckle is required. Overall length: 14.0 mm....
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
...
...
Medicine Products: